SEC Form 4 · accession 0001077183-19-000027
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Bonello
Officer — Chief Strategy Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 4:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2019 | A | 6,735 | $0.00 | A | 6,735 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.60 | Mar 1, 2019 | A | 41,167 | A | Mar 1, 2020 | Mar 1, 2024 | Common Stock | 41,167 | 41,167 | D |
| Stock Option (Right to Buy)F2 | $8.03 | holding | — | — | — | Feb 26, 2019 | Feb 26, 2023 | Common Stock | 80,334 | 80,334 | D |
| Stock Option (Right to Buy)F3 | $7.52 | holding | — | — | — | Apr 28, 2018 | Apr 28, 2022 | Common Stock | 79,963 | 79,963 | D |
Explanation of responses
- F1On March 1, 2019, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
- F2On February 26, 2018, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
- F3On April 28, 2017, Mr. Bonello was granted an option to purchase shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.